Abstract
We aimed to compare apparent steady-state oral clearance (CL/F) of the antiepileptic drug levetiracetam (LEV) in elderly (66-80 years, n=105) and very elderly (81-96 years, n=70) vs nonelderly (30-65 years, n=97) patients with epilepsy. Median weight-normalized CL/F (mLmin -1kg -1) decreased from 1.23 (nonelderly) to 0.83 (elderly) and 0.59 (very elderly) (p
Original language | English |
---|---|
Pages (from-to) | 130-134 |
Number of pages | 5 |
Journal | Epilepsy Research |
Volume | 98 |
Issue number | 2-3 |
DOIs | |
Publication status | Published - Feb 2012 |
Keywords
- Elderly and very elderly patients
- Levetiracetam
- Oral clearance
- Pharmacokinetics
- Therapeutic drug monitoring
ASJC Scopus subject areas
- Clinical Neurology
- Neurology